NCT07551440: Pilot Observational Study of Gastric Cancer Metastases
Summary
A pilot observational study (NCT07551440) titled 'Identification of Therapeutic Targets in Metastatic Gastric Cancer' was registered on April 24, 2026. The study aims to identify novel therapeutic molecular targets in patients diagnosed with gastric cancer with lymph node or distant metastases. All eligible patients will be screened at the Prince of Wales Hospital. The study is registered as an observational study with conditions listed as Stomach Neoplasms, Benign. This is a clinical trial registry entry providing public access to study information as required by clinical research registration standards.
“This is a pilot study aiming at identifying novel therapeutic molecular targets in patients with gastric cancer with lymph nodes or distant metastasis.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
A pilot observational study (NCT07551440) was registered on ClinicalTrials.gov, a database maintained by the National Library of Medicine at the NIH. The study titled 'Identification of Therapeutic Targets in Metastatic Gastric Cancer' will screen patients at Prince of Wales Hospital who are diagnosed with gastric cancer with metastases. The study focuses on identifying novel therapeutic molecular targets for patients with lymph node or distant metastasis.
Healthcare providers and clinical investigators conducting similar oncology research should note this study's registration. It represents one of many targeted therapy identification studies being conducted globally in the gastric cancer space. The study's observational design means it will observe and analyze patient data rather than intervening with new treatments. Researchers studying metastatic gastric cancer may find this trial relevant for understanding current therapeutic target identification approaches.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Identification of Therapeutic Targets in Metastatic Gastric Cancer
Observational NCT07551440 Kind: OBSERVATIONAL Apr 24, 2026
Abstract
This is a pilot study aiming at identifying novel therapeutic molecular targets in patients with gastric cancer with lymph nodes or distant metastasis. All patients who are diagnosed with gastric cancer with metastases in the Prince of Wales Hospital will be screened for eligibility.
Conditions: Stomach Neoplasms, Benign
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.